When considering log(KG), there is a significant difference between MTC, NSCLC and Other RET fusion-positive (FUS)/RET-altered (ALT) (i.e., excluding RET fusion-positive) tumors (Figure 1C). The gene discussed is GPT; the disease is medullary thyroid gland carcinoma.